Pfizer Completes Acquisition of Vicuron Pharmaceuticals
Pfizer Inc completed its acquisition of Vicuron Pharmaceuticals Inc., a biopharmaceutical company focused on the development of novel anti-infectives for both hospital-based and community-acquired infections. In connection with the closing, shares of Vicuron common stock have been delisted from the Nasdaq and Italy's Nuovo Mercato stock exchanges.
Through the transaction, Pfizer has acquired two new product candidates currently under review at the U.S. Food and Drug Administration (FDA): anidulafungin for fungal infections and dalbavancin for Gram-positive infections. The addition of these product candidates broadens Pfizer's presence in anti-infectives where the company has a long history of providing patients and physicians with life-saving medicines.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Stepan Company Names James E. Hurlbutt, Vice President and Chief Financial Officer
BGU researchers successfully test an engineered oasis for solar desalination and arid land agriculture
Wet weather coatings
Bisphenol A: EFSA consults on assessment of risks to human health

A noble gas cage - New material traps gases from nuclear fuel better and uses less energy than currently available options
Borouge to invest in automotive market with new compounding facility in China
Matrix and Aspen, South Africa, finalize Strategic business relationship
